Áß¾Ó´ëÇб³ »ý¸íÀǾ࿬±¸¿ø(¿øÀå ¼¼ºÁØ)Àº ¿À´Â 11¿ù 8ÀÏ, ¿ÀÈÄ 2½ÃºÎÅÍ Áß¾Ó´ëÇб³ R&D¼¾ÅÍ 222È£¿¡¼ ‘Skin Barrier and Drug Delivery’¶ó´Â Á¦¸ñÀ¸·Î 2013³â ±¹Á¦Çмú´ëȸ¸¦ °³ÃÖÇÑ´Ù.
Áß¾Ó´ëÇб³ »ý¸íÀǾ࿬±¸¿øÀÌ ÁÖ°üÇÏ°í Á߾Ӵ뺴¿ø ÀÓ»ó½ÃÇè¼¾ÅÍ°¡ ÈÄ¿øÇÏ´Â À̹ø ±¹Á¦Çмú´ëȸ´Â ÇǺÎÀ庮°ú À̸¦ ÅëÇÑ ¾à¹°µéÀÇ ¿î¼Û¿¡ °ü·ÃµÈ À¶ÇÕ¹ÙÀÌ¿À ÀǾ࿬±¸¸¦ ÁÖÁ¦·Î ÃÑ 3°³ÀÇ ¼¼¼ÇÀ¸·Î ³ª´µ¾î ÁøÇàµÈ´Ù.
Á¦ 1¼¼¼Ç¿¡¼´Â ¡ãModulation of electroosmosis and flux through skin: effect of propylene glycol(¼÷¸í¿©´ë ¿À½Â¿ ±³¼ö) ¡ãTransdermal drug delivery using microdevices(°¡Ãµ´ë ¹ÚÁ¤È¯ ±³¼ö) ¡ãLipid-based topical drug delivery systems for chemical and biopharmaceutical drugs(°è¸í´ë ÀÌ»ó±æ ±³¼ö) µîÀÇ ³»¿ëÀ¸·Î ÁøÇàµÈ´Ù.
Á¦ 2¼¼¼ÇÀº ¡ãPermeability barrier formation in skin (Cosmax ¿°Á¾°æ ¹Ú»ç) ¡ãSkin delivery (Àü³²´ë ±è¼ºÁø ±³¼ö) ¡ãSkin barrier and innate immunity (¼¿ï´ë Á¶¼Ò¿¬ ±³¼ö)ÀÇ ¼ø¼·Î ÁøÇàµÉ ¿¹Á¤ÀÌ´Ù.
¸¶Áö¸· Á¦ 3¼¼¼ÇÀº ¡ãDevelopment of immunoassay using monoclonal antibody and recombinant antibody for natural products (Kyushu University Prof. Hiroyuki Tanaka)¿¡ ´ëÇØ Åä·ÐÇÏ´Â ½Ã°£À» °¡Áú ¿¹Á¤ÀÌ´Ù.
À̹ø ±¹Á¦Çмú´ëȸ¸¦ ÁغñÇÑ ¼¼ºÁØ ±³¼ö(Á߾Ӵ뺴¿ø ÇǺΰú)´Â “2002³â Áß¾Ó´ëÇб³ÀÇ BTºÐ¾ß Àü·«Æ¯¼ºÈ »ç¾÷ÀÇ ÀÏȯÀ¸·Î ¼³¸³µÈ »ý¸íÀǾ࿬±¸¿øÀº Áö³ 10³â°£ »ý¸íÀǾ࿬±¸»ç¾÷°ú ´ëÇü±¹Ã¥¿¬±¸»ç¾÷ µîÀ» ¼öÇàÇÏ¸é¼ Áß¾Ó´ëÇб³ÀÇ »ý¸íÀǾàºÐ¾ßÀÇ ¹ßÀüÀ» À§ÇØ ²ÙÁØÈ÷ ³ë·ÂÇØ¿Ô´Ù.”¸ç, “À̹ø Çмú´ëȸ¸¦ ÅëÇØ ±×µ¿¾ÈÀÇ ¼º°ú¸¦ Åä´ë·Î »õ·Î¿î ¹æÇâ°ú ¸ñÇ¥¸¦ ÀçÁ¶¸íÇÏ´Â ±âȸ·Î »ï°Ú´Ù.”°í ÀüÇß´Ù.